Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Neurology | Family Medicine
Search Medical Condition
Neuropathy Clinical Trials
A listing of Neuropathy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (307) clinical trials
To evaluate the efficacy of multiple dose levels of NYX-2925 versus placebo in treating the neuropathic pain associated with Diabetic Peripheral Neuropathy.
This study will see if an investigational drug called NYX-2925 can reduce the nerve pain in the legs and feet associated with painful diabetic peripheral neuropathy.
Diabetic Neuropathy in Type 1 and 2 Diabetics
Northern California Research is conducting a study for diabetic peripheral neuropathy (DPN). DPN is a type of nerve damage that can occur if you have diabetes. This study is for men and women who are experiencing painful diabetic peripheral neuropathy in both lower extremities (legs). The specific events that result ...
This clinical study will measure the effectiveness of a new adjunctive treatment for people with type 1 diabetes.
The purpose of this study is to evaluate the effectiveness of empagliflozin as a complimentary treatment to people with type 1 diabetes.
A PHASE III, OPEN LABEL, EXTENSION TRIAL OF ECU-NMO-301 TO EVALUATE THE SAFETY AND EFFICACY OF ECULIZUMAB IN PATIENTS WITH RELAPSING NEUROMYELITIS OPTICA (NMO) STUDY NUMBER: ECU-NMO-302
This is an extension trial to ECU-NMO-301 trial. A maximum of 132 patients are planned to be enrolled in the ECU-NMO-301 trial. This extension trial will be open to all patients who have completed the ECU-NMO-301 trial and meet the eligibility criteria.
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial to Evaluate the Safety and Efficacy of Eculizumab in Patients With Relapsing Neuromyelitis Optica (Nmo)
EudraCT Number 2013-001150-10 STUDY NUMBER: ECU-NMO-301 Neuromyelitis Optica (NMO) or NMO Spectrum Disorders (NMOSD), also known as Devic’s Disease, is a rare, severe disabling autoimmune inflammatory disorder of the central nervous system (CNS) that predominately affects the optic nerves and spinal cord, and is often characterized by a relapsing course. ...
Double-blind, placebo-controlled, parallel group, single-injection study in which subjects will be randomized to receive three doses of CNTX-4975 or placebo injected into the intermetatarsal space around a Morton's neuroma.
The injection of study medication will be administered by ultrasound-guided needle placement following ankle block anesthesia. The study staff will telephone subjects at Week 1 postinjection and subjects will return to the clinic postinjection at Weeks 2, 4, 8, and 12 for study assessments.
Painful Diabetic Peripheral Neuropathy
Suffering from Diabetic Neuropathy? If you suffer from Diabetic Peripheral Neuropathy, also known as DPN, you may be interested in learning more about a research study of an investigational medication being conducted locally.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy.
The objectives of the MEDIAN study are to evaluate the short-term and long-term safety and nutritional benefits of Metanx® versus placebo in subjects with mild to moderate diabetic peripheral neuropathy (DPN). Short-term effects will be evaluated during the first 16 weeks of treatment, and long-term effects will be evaluated over ...
Diabetic Peripheral Neuropathy Research Study
Endeavor Clincial Trials is seeking volunteers to participate in a Diabetic Peripheral Neuropathy (DPN) research study.
Diabetic Neuropathy
Do you suffer from persistent burning, throbbing, or tingling pain in your feet? Are you currently taking medication for this pain?
